These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4929149)

  • 41. Comparison of the effect of thyrotropin and long-acting thyroid stimulator on glucose oxidation and endocytosis in canine thyroid slices.
    Shishiba Y; Solomon DH; Davidson WD
    Endocrinology; 1970 Feb; 86(2):183-90. PubMed ID: 5409920
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative studies on the reduction of the response to the long-acting thyroid stimulator by soluble fractions from human, ovine, bovine and porcine thyroids.
    Dirmikis S; Munro DS
    J Endocrinol; 1973 Dec; 59(3):579-92. PubMed ID: 4761687
    [No Abstract]   [Full Text] [Related]  

  • 43. Changes in the solubility of immunoglobulins after fluorescent labeling and its influence on immunofluorescent techniques.
    Arnold W; von Mayersbach H
    J Histochem Cytochem; 1972 Dec; 20(12):975-85. PubMed ID: 4118359
    [No Abstract]   [Full Text] [Related]  

  • 44. Isoelectric focusing of long-acting thyroid stimulator (LATS) containing IgG.
    Schleusener H; Adlkofer F; Uher L; Kaper-Czygan S; Kirstaedter HJ
    Horm Metab Res; 1971 May; 3(3):221-2. PubMed ID: 5171402
    [No Abstract]   [Full Text] [Related]  

  • 45. The value of IgG separation for the detection of LATS in human serum.
    Bonnyns M; Vanhaelst L
    Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of prostaglandins on basal and stimulated thyroid function.
    Burke G
    Am J Physiol; 1970 May; 218(5):1445-52. PubMed ID: 4314571
    [No Abstract]   [Full Text] [Related]  

  • 47. Inactivation of long-acting thyroid stimulator in vivo.
    Smith BR; Munro DS
    J Endocrinol; 1972 Jan; 52(1):189-96. PubMed ID: 5061150
    [No Abstract]   [Full Text] [Related]  

  • 48. Subcellular distribution of 32 P labelled phospholipids: stimulation by thytropar and long acting thyroid stimulator.
    Satyaswaroop PG
    Experientia; 1971; 27(11):1345-6. PubMed ID: 5134311
    [No Abstract]   [Full Text] [Related]  

  • 49. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
    Tourneur R; Letonturier P; Sénécal P
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
    [No Abstract]   [Full Text] [Related]  

  • 50. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract]   [Full Text] [Related]  

  • 51. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of immunization of baboons with human thyroid tissue.
    Beall GN; Daniel PM; Pratt OE; Solomon DH
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1460-9. PubMed ID: 4981680
    [No Abstract]   [Full Text] [Related]  

  • 53. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
    Furth ED; Dentinger M
    Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of the long-acting thyroid stimulator (LATS) on radioiodine-labelled thyroxine and triiodothyronine in the thyroid of mice.
    Emrich D; von Toll-Jürgens KH; zur Mühlen A Von
    Endocrinology; 1970 Sep; 87(3):632-6. PubMed ID: 5424582
    [No Abstract]   [Full Text] [Related]  

  • 55. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 56. The immunoglobulin G (IgG) of Graves' disease: thyroid stimulation by fraction and fragment.
    Burke G
    Endocrinology; 1969 May; 84(5):1063-70. PubMed ID: 4887860
    [No Abstract]   [Full Text] [Related]  

  • 57. TSH- or LATS-stimulated thyroid hormone release is inhibited by iodide.
    Ochi Y; DeGroot LJ
    Endocrinology; 1969 Jun; 84(6):1305-9. PubMed ID: 5781122
    [No Abstract]   [Full Text] [Related]  

  • 58. Direct evidence for human thyroidal stimulation by LATS-protector.
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
    [No Abstract]   [Full Text] [Related]  

  • 59. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
    [No Abstract]   [Full Text] [Related]  

  • 60. Non-specific responses in the assay of thyrotrophin and long-acting thyroid stimulator.
    Adams DD; Kennedy TH; Purves HD
    Aust J Exp Biol Med Sci; 1966 Aug; 44(4):355-64. PubMed ID: 5967342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.